[HTML][HTML] Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi, F Quehenberger… - Genome medicine, 2013 - Springer
Background Patients with prostate cancer may present with metastatic or recurrent disease
despite initial curative treatment. The propensity of metastatic prostate cancer to spread to …

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi… - Genome …, 2013 - mdanderson.elsevierpure.com
Background: Patients with prostate cancer may present with metastatic or recurrent disease
despite initial curative treatment. The propensity of metastatic prostate cancer to spread to …

[HTML][HTML] Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi… - Genome …, 2013 - ncbi.nlm.nih.gov
Background Patients with prostate cancer may present with metastatic or recurrent disease
despite initial curative treatment. The propensity of metastatic prostate cancer to spread to …

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi… - 2013 - opus.bibliothek.uni-augsburg.de
Background Patients with prostate cancer may present with metastatic or recurrent disease
despite initial curative treatment. The propensity of metastatic prostate cancer to spread to …

[引用][C] Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi, F Quehenberger… - Genome Medicine, 2013 - cir.nii.ac.jp
Tumor-associated copy number changes in the circulation of patients with prostate cancer
identified through whole-genome sequencing | CiNii Research CiNii 国立情報学研究所 学術 …

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi… - Genome …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Patients with prostate cancer may present with metastatic or recurrent disease
despite initial curative treatment. The propensity of metastatic prostate cancer to spread to …

[PDF][PDF] Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi, F Quehenberger… - 2013 - researchgate.net
Background: Patients with prostate cancer may present with metastatic or recurrent disease
despite initial curative treatment. The propensity of metastatic prostate cancer to spread to …

[HTML][HTML] Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi… - Genome …, 2013 - genomemedicine.biomedcentral …
Patients with prostate cancer may present with metastatic or recurrent disease despite initial
curative treatment. The propensity of metastatic prostate cancer to spread to the bone has …

[PDF][PDF] Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi, F Quehenberger… - 2013 - cyberleninka.org
Background: Patients with prostate cancer may present with metastatic or recurrent disease
despite initial curative treatment. The propensity of metastatic prostate cancer to spread to …

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

E Heitzer, P Ulz, J Belic, S Gutschi, F Quehenberger… - Genome, 2013 - hero.epa.gov
BACKGROUND: Patients with prostate cancer may present with metastatic or recurrent
disease despite initial curative treatment. The propensity of metastatic prostate cancer to …